← Back

Shandong Wohua Pharmaceutical Co Ltd

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gusukang capsules/granules and Yidu Hanbi liquid; Yidu cold-rheumatism medicinal wine ingredients; brain blood circulation oral solution; Amber stone granules for urinary system diseases; Children's antipyretic granules for pediatric medication; Anti-itching granules for skin diseases; and Bile grass capsule for digestive and gynecological diseases, as well as Silkworm Nourishing Blood and Benefiting Kidney Granules for gynecological medication. In addition, the company offers Amber Xiaoshi granules, and Siyu Yangxue Yishen granules; Yanreqing granules, Antiviral oral liquid, and Niuhuang Yijin tablets for the treatment of dry throat and sore throat; Yinhuang granules for the treatment of wind-heat colds; Tongxuan Lifei pills for the treatment of wind-cold colds; Fangfeng Tongsheng pills for colds on the surface and heat inside; Huoxiang Zhengqi Water for the treatment of summer-heat colds; Shenling Baizhu, Buzhong Yiqi, and Xiangsha Liujun pills for the treatment of physical weakness colds; and Juhong Li Gao for the treatment of dry coughs with little sputum. The company was founded in 2003 and is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. operates as a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Price · split & dividend adjusted
News & notes moving 002107.CS
002107.CS

Multiple A-share Companies Announce Mid-Year Dividends; Action Education Plans 12 Yuan per 10 Shares

On the evening of August 11, several A-share listed companies released their 2026 mid-year dividend implementation plans or proposals. Among them, Action Education plans to distribute a cash dividend of 12 yuan per 10 shares, including tax, totaling 143 million yuan. Xinjiang Xintianran Gas plans to distribute 8 yuan per 10 shares, including tax, with an estimated total payout of 339 million yuan. Jangho Group plans to distribute 0.25 yuan per share, including tax, with an estimated total payout of 283 million yuan. Hikvision released its equity distribution implementation announcement, proposing a cash dividend of 5.50 yuan per 10 shares, including tax, to all shareholders, with a cumulative total dividend of 5.041 billion yuan. The record date is August 18. In addition, Yongjin Technology, Wohua Pharmaceutical, Hubei Yihua, Great Wall Sci-Tech, Dongbai Group, and Fushine Pharmaceutical also disclosed their dividend plans.
证券时报·15dRead more ▾
002107.CS2

Wohua Pharmaceutical's 2026 Interim Net Profit Rises 51.23% Year-on-Year

Wohua Pharmaceutical released its 2026 interim report, with net profit attributable to the parent company at 67.5663 million yuan, up 51.23% from the same period last year, marking two consecutive years of growth. The company's total operating revenue was 393 million yuan, down 7.53% year-on-year. Net cash inflow from operating activities was 81.3675 million yuan, an increase of 8.07% year-on-year. The company's latest asset-liability ratio is 26.32%, gross margin is 77.84%, ROE is 9.56%, and diluted earnings per share is 0.12 yuan.
Jiemian·42dRead more ▾